RAMONE, TERESA
 Distribuzione geografica
Continente #
NA - Nord America 827
EU - Europa 562
AS - Asia 106
AF - Africa 49
SA - Sud America 2
OC - Oceania 1
Totale 1.547
Nazione #
US - Stati Uniti d'America 821
IT - Italia 222
SE - Svezia 108
AT - Austria 88
DE - Germania 59
SG - Singapore 44
BG - Bulgaria 40
CI - Costa d'Avorio 32
GB - Regno Unito 29
CN - Cina 22
SN - Senegal 14
VN - Vietnam 13
HK - Hong Kong 10
CA - Canada 6
IN - India 5
IR - Iran 5
RU - Federazione Russa 5
CH - Svizzera 3
JP - Giappone 3
IL - Israele 2
AU - Australia 1
BE - Belgio 1
BR - Brasile 1
DK - Danimarca 1
EG - Egitto 1
FR - Francia 1
GR - Grecia 1
IE - Irlanda 1
IS - Islanda 1
KZ - Kazakistan 1
NG - Nigeria 1
PE - Perù 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 1.547
Città #
Chandler 139
Fairfield 109
Milan 98
Vienna 86
Ashburn 53
Woodbridge 52
Seattle 51
Cambridge 47
Sofia 40
Wilmington 40
Houston 37
New York 36
Abidjan 32
Princeton 23
Redmond 20
Florence 19
Lawrence 19
Beijing 15
Dakar 14
Medford 14
London 13
Rome 13
Ann Arbor 11
Chiesina Uzzanese 11
Frankfurt am Main 11
Pisa 11
Bremen 10
Hong Kong 10
Redwood City 10
Serra 10
Los Angeles 7
Dong Ket 6
Urmia 5
Dearborn 4
Montale 4
Norwalk 4
San Diego 4
Singapore 4
Cleveland 3
Tianjin 3
Vicopisano 3
Bergamo 2
Chiswick 2
Crick 2
Des Moines 2
Edinburgh 2
Geneva 2
Genoa 2
Gurgaon 2
Irsina 2
Ottawa 2
Pian Camuno 2
Scandicci 2
Toronto 2
Washington 2
Yonkers 2
Acton 1
Adelaide 1
Atikokan 1
Augusta 1
Azor 1
Bangalore 1
Bratislava 1
Copenhagen 1
Dublin 1
Guangzhou 1
Hefei 1
Johannesburg 1
Krasnoyarsk 1
Lagos 1
Lima 1
Misr 1
Montreal 1
Moscow 1
Murfreesboro 1
Nanjing 1
Nantes 1
Napoli 1
Nishi-Tokyo-shi 1
Ogden 1
Oral 1
Osimo 1
Phoenix 1
Reggio Nell'emilia 1
Reykjavik 1
Riyadh 1
Saint Paul 1
Saint Petersburg 1
San Francisco 1
Schaumburg 1
Shenyang 1
Show Low 1
St Louis 1
Tomsk 1
Wolverhampton 1
Zandhoven 1
Zurich 1
Totale 1.172
Nome #
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 141
Medullary thyroid cancer treated with vandetanib: predictors of longer and durable response 141
Next generation sequencing revealed RET or RAS mutation in medullary thyroid cancer that were negative at sanger sequencing 121
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 119
Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma 117
Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations 113
GENETIC LANDSCAPE OF SOMATIC MUTATIONS IN A LARGE COHORT OF SPORADIC MEDULLARY THYROID CARCINOMAS STUDIED BY NEXT GENERATION TARGETED SEQUENCING 102
Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas 91
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion 79
MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis? 75
MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children 64
RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency 61
Fenotipo misto MEN2A/MEN2B da nuova mutazione germinale di RET: prima descrizione clinico-genetica e iconografia 58
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 54
RET mutated C-cells proliferate more rapidly than non-mutated neoplastic cells 42
Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer 36
Ret mutated c-cells proliferate more rapidly than non-mutated neoplastic cells 35
Active surveillance in ret gene carriers belonging to families with multiple endocrine neoplasia 35
Higher RET gene expression levels do not represent an alternative RET activation mechanism in medullary thyroid carcinoma 27
Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment 24
The prognostic role of chromosomal gains and loss in sporadic medullary thyroid carcinoma 17
Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome 16
Somatic RET Indels in Sporadic Medullary Thyroid Cancer: Prevalence and Response to Selpercatinib 13
NF1 Gene Inactivation Acts as Tumor Driver in RET/RAS Negative Medullary Thyroid Carcinomas 11
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients 8
Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients 3
Totale 1.603
Categoria #
all - tutte 5.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.295


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201910 0 0 0 0 0 0 0 0 0 0 6 4
2019/2020325 15 8 11 34 34 47 37 30 33 28 38 10
2020/2021202 16 5 16 4 2 26 41 25 22 12 5 28
2021/2022209 14 3 1 1 40 28 12 14 9 11 26 50
2022/2023532 50 70 51 50 54 68 4 47 96 2 32 8
2023/2024315 36 38 59 43 53 50 20 6 3 7 0 0
Totale 1.603